Substituted naphthyridines and their use as medicaments

US9187478B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Matthias Hoffmann · Mittelbiberach, DE
• Georg Dahmann · Biberach an der Riß, DE
• Dennis Fiegen · Biberach an der Riß, DE
• Sandra Handschuh · Biberach an der Riß, DE
• Jasna Klicic · Biberach an der Riß, DE
• Guenter Linz · Mittelbiberach, DE
• Gerhard Schaenzle · Biberach, DE
• Andreas Schnapp · Biberach, DE
• Stephen Peter East · Wallingford, GB
• Michael Philip Mazanetz · Abingdon, GB
• Robert John Scott · Abingdon, GB
• Edward Walker · Biggenden, AU

Key dates

• Filing date: Jan 8, 2015
• Grant date: Nov 17, 2015
• Expiry date: Jan 8, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D519/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to new substituted naphthyridines of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof,wherein wherein n is either 0 or 1,